About Truvic
Truvic is a company based in Campbell (United States) founded in 2014 was acquired by Imperative Care in July 2021. Truvic has raised $5.89 million across 1 funding round from investors including Imperative Care. Truvic offers products and services including Zoom Aspiration Catheters, Prodigy, and Symphony. Truvic operates in a competitive market with competitors including Avinger, Pathway Medical Technologies, Intact Vascular, LeMaitre Vascular and Okami Medical, among others.
- Headquarter Campbell, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Imperative Care, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$5.89 M (USD)
in 1 rounds
-
Latest Funding Round
$5.89 M (USD), Series A
Jul 09, 2020
- Investors
-
Employee Count
Not available
-
Acquired by
Imperative Care
(Jul 15, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Truvic
Truvic offers a comprehensive portfolio of products and services, including Zoom Aspiration Catheters, Prodigy, and Symphony.
Tools for aspiration in stroke procedures to remove clots.
Device for treating acute limb ischemia by clearing blood clots.
System providing real-time feedback for vascular clot removal.
Funding Insights of Truvic
Truvic has successfully raised a total of $5.89M through 1 strategic funding round. The most recent funding activity was a Series A round of $5.89 million completed in July 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Truvic
Truvic has secured backing from 1 investor. Prominent investors backing the company include Imperative Care.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Access catheters for neurovascular stroke treatment are provided.
|
Locked | Locked | Locked |
Investor details for Truvic
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Truvic
Investment portfolio details for Truvic
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Truvic
Detailed financials for Truvic
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Truvic Comparisons
Peer comparison for Truvic
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Truvic
Truvic operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avinger, Pathway Medical Technologies, Intact Vascular, LeMaitre Vascular and Okami Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of image-guided catheter-based products for peripheral artery disease
|
|
| Locked | Locked | Locked |
Smart devices are provided to clear peripheral arterial blockages.
|
|
| Locked | Locked | Locked |
Implants for repairing arteries after angioplasty are developed.
|
|
| Locked | Locked | Locked |
Devices for peripheral vascular disease treatment are developed and marketed.
|
|
| Locked | Locked | Locked |
Innovative medical devices for peripheral vessel treatment are developed.
|
|
| Locked | Locked | Locked |
Devices for removing vascular blockages are developed.
|
Detailed competitors of Truvic
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Truvic
Complete news archive for Truvic
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Truvic
Truvic was founded in 2014 and raised its 1st funding round 6 years after it was founded.
Truvic is headquartered in Campbell, United States. It is registered at Campbell, California, United States.
Mike Buck is the current CEO of Truvic.
Truvic is a funded company, having raised a total of $5.89M across 1 funding round to date.
Truvic was founded in 2014 and is headquartered in Campbell, United States. Focus is placed on the medical device sector, where smart devices are developed for managing peripheral vascular diseases. Operations center on enabling single-session thrombus removal without thrombolytics. These devices address thrombus management in peripheral vascular conditions, supporting clinical interventions in the healthcare field.
Truvic's top competitors include Avinger, Okami Medical and Cagent Vascular.
Truvic offers Zoom Aspiration Catheters, Prodigy, and Symphony.
Truvic has 1 investor. Key investors include Imperative Care.